Cardlytics (CDLX) Tops Q2 EPS by 31c

Go back to Cardlytics (CDLX) Tops Q2 EPS by 31c

Needham Downgrades Cardlytics (CDLX) to Hold

August 8, 2024 7:12 AM EDT

Needham analyst Kyle Peterson downgraded Cardlytics (NASDAQ: CDLX) from Buy to Hold.

The analyst comments "CDLX's 2Q results missed expectations across the board, as weak billings resulted in another light quarter. More troubling was that this is the second quarter in... More